Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

BNTCBNTC
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in BENITEC BIOPHARMA INC

GOLDMAN SACHS GROUP INC holds 178,041 shares of BNTC (BENITEC BIOPHARMA INC), worth $2.4M as of 2026-Q2. The position was decreased (-17.4% shares). BNTC represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$2.4M

Current Shares

178,041

Total Value Change

+$1.8M

Total Shares Change

+132,158

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
178,041
-17.4%
$2.4M0.0%$13.38
0
2026-Q1
Increased
215,476
+23.8%
$2.3M0.0%$10.46
32
2025-Q4
Decreased
174,041
-10.5%
$2.3M0.0%$13.93
0
2025-Q3
Increased
194,363
+825.8%
$2.7M0.0%$13.99
42
2025-Q2
Decreased
20,994
-54.2%
$245,6300.0%$11.35
0
2025-Q1
New
45,883
-
$596,9380.0%$13.43
34

Other major holders of BNTC: Janus Henderson Group Ltd., FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used